Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Scully

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancer Discovery|September 26, 2014
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repairYiduo Hu, Sarah A Petit, Scott B Ficarro, et al.
Journal of Medical Genetics|March 11, 2020
Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotationAlvaro N Monteiro, Peter Bouwman, Arne N Kousholt, et al.
Nucleic Acids Research|March 7, 2014
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathwaysCarole Beck, Christian Boehler, Josée Guirouilh Barbat, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2002
Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AXCraig H Bassing, Katrin F Chua, JoAnn Sekiguchi, et al.
Cancer Research|March 21, 2020
Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP InhibitionMan-Li Luo, Fang Zheng, Wenying Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2016
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletionAshish Juvekar, Hai Hu, Sina Yadegarynia, et al.
Cell|December 2, 2008
SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during agingPhilipp Oberdoerffer, Shaday Michan, Michael McVay, et al.
Cancer Discovery|August 24, 2012
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancerAshish Juvekar, Laura N Burga, Hai Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
The tandem duplicator phenotype as a distinct genomic configuration in cancerFrancesca Menghi, Koichiro Inaki, XingYi Woo, et al.
Science Advances|August 28, 2021
Lamin B1 sequesters 53BP1 to control its recruitment to DNA damageLaure Etourneaud, Angela Moussa, Emilie Rass, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancer Discovery|September 26, 2014
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repairYiduo Hu, Sarah A Petit, Scott B Ficarro, et al.
Journal of Medical Genetics|March 11, 2020
Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotationAlvaro N Monteiro, Peter Bouwman, Arne N Kousholt, et al.
Nucleic Acids Research|March 7, 2014
PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathwaysCarole Beck, Christian Boehler, Josée Guirouilh Barbat, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2002
Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AXCraig H Bassing, Katrin F Chua, JoAnn Sekiguchi, et al.
Cancer Research|March 21, 2020
Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP InhibitionMan-Li Luo, Fang Zheng, Wenying Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2016
Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletionAshish Juvekar, Hai Hu, Sina Yadegarynia, et al.
Cell|December 2, 2008
SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during agingPhilipp Oberdoerffer, Shaday Michan, Michael McVay, et al.
Cancer Discovery|August 24, 2012
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancerAshish Juvekar, Laura N Burga, Hai Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
The tandem duplicator phenotype as a distinct genomic configuration in cancerFrancesca Menghi, Koichiro Inaki, XingYi Woo, et al.
Science Advances|August 28, 2021
Lamin B1 sequesters 53BP1 to control its recruitment to DNA damageLaure Etourneaud, Angela Moussa, Emilie Rass, et al.
Pageof 8